Consolidated Quarterly Holdings Report
for
Fidelity® Growth Company K6 Fund
February 28, 2026
GCF-K6-NPRT1-0426
1.9893922.106
Common Stocks - 95.9%
 
 
Shares
Value ($)
 
BELGIUM - 0.2%
 
 
 
Health Care - 0.2%
 
 
 
Pharmaceuticals - 0.2%
 
 
 
AgomAb Therapeutics NV (f)
 
397,360
6,365,708
AgomAb Therapeutics NV ADR
 
143,200
2,294,064
UCB SA
 
88,289
26,320,512
 
 
 
 
TOTAL BELGIUM
 
 
34,980,284
CANADA - 0.7%
 
 
 
Consumer Discretionary - 0.0%
 
 
 
Textiles, Apparel & Luxury Goods - 0.0%
 
 
 
Canada Goose Holdings Inc Subordinate Voting Shares (c)
 
343,142
4,226,227
Energy - 0.1%
 
 
 
Oil, Gas & Consumable Fuels - 0.1%
 
 
 
Cameco Corp (United States)
 
194,492
23,027,853
Information Technology - 0.1%
 
 
 
Electronic Equipment, Instruments & Components - 0.0%
 
 
 
Celestica Inc (United States) (c)
 
15,823
4,392,939
IT Services - 0.1%
 
 
 
Shopify Inc Class A (c)
 
217,303
26,233,119
Software - 0.0%
 
 
 
Taalas Inc warrants (c)(d)(e)
 
508,939
615,816
TOTAL INFORMATION TECHNOLOGY
 
 
31,241,874
Materials - 0.5%
 
 
 
Metals & Mining - 0.5%
 
 
 
Agnico Eagle Mines Ltd/CA (United States)
 
138,315
34,800,054
Barrick Mining Corp (b)
 
619,954
31,455,604
Franco-Nevada Corp (United States)
 
47,774
13,405,862
Kinross Gold Corp (United States)
 
137,874
5,099,959
Novagold Resources Inc (United States) (c)
 
941,068
12,535,026
TOTAL MATERIALS
 
 
97,296,505
TOTAL CANADA
 
 
155,792,459
CHINA - 0.3%
 
 
 
Consumer Discretionary - 0.3%
 
 
 
Broadline Retail - 0.1%
 
 
 
Alibaba Group Holding Ltd ADR (b)
 
166,614
24,010,744
Hotels, Restaurants & Leisure - 0.2%
 
 
 
Atour Lifestyle Holdings Ltd ADR
 
441,181
17,325,178
Luckin Coffee Inc ADR (c)
 
472,620
16,532,247
 
 
 
33,857,425
TOTAL CONSUMER DISCRETIONARY
 
 
57,868,169
Health Care - 0.0%
 
 
 
Biotechnology - 0.0%
 
 
 
Zai Lab Ltd ADR (b)(c)
 
133,655
2,568,849
TOTAL CHINA
 
 
60,437,018
DENMARK - 0.1%
 
 
 
Health Care - 0.1%
 
 
 
Biotechnology - 0.1%
 
 
 
Ascendis Pharma A/S ADR (c)
 
16,436
3,837,806
Galecto Inc (c)
 
521,922
15,438,453
Zealand Pharma A/S (c)
 
228,330
13,135,944
 
 
 
32,412,203
Pharmaceuticals - 0.0%
 
 
 
Novo Nordisk A/S Class B ADR
 
1,112
41,644
TOTAL DENMARK
 
 
32,453,847
FINLAND - 0.3%
 
 
 
Information Technology - 0.3%
 
 
 
Communications Equipment - 0.3%
 
 
 
Nokia Oyj ADR
 
10,150,870
78,364,716
FRANCE - 0.1%
 
 
 
Health Care - 0.1%
 
 
 
Biotechnology - 0.1%
 
 
 
Abivax SA ADR (c)
 
97,266
11,796,420
Health Care Technology - 0.0%
 
 
 
DNA Script SAS (c)(d)(e)
 
439
6,178
DNA Script SAS (c)(d)(e)
 
115
1,616
 
 
 
7,794
TOTAL FRANCE
 
 
11,804,214
GERMANY - 0.1%
 
 
 
Consumer Discretionary - 0.0%
 
 
 
Textiles, Apparel & Luxury Goods - 0.0%
 
 
 
Adidas AG
 
19
3,525
Birkenstock Holding Plc (c)
 
8,571
356,982
TOTAL CONSUMER DISCRETIONARY
 
 
360,507
Health Care - 0.1%
 
 
 
Biotechnology - 0.1%
 
 
 
BioNTech SE ADR (c)
 
170,287
18,770,737
Tubulis GmbH (d)(e)(g)
 
2,200
789,682
TOTAL HEALTH CARE
 
 
19,560,419
TOTAL GERMANY
 
 
19,920,926
INDIA - 0.2%
 
 
 
Consumer Discretionary - 0.1%
 
 
 
Broadline Retail - 0.1%
 
 
 
Meesho (f)
 
9,282,542
16,316,886
Hotels, Restaurants & Leisure - 0.0%
 
 
 
MakeMyTrip Ltd (b)(c)
 
112,306
6,341,920
Specialty Retail - 0.0%
 
 
 
Lenskart Solutions Ltd (c)
 
198,182
1,170,144
TOTAL CONSUMER DISCRETIONARY
 
 
23,828,950
Energy - 0.0%
 
 
 
Oil, Gas & Consumable Fuels - 0.0%
 
 
 
Reliance Industries Ltd
 
368,492
5,643,352
Financials - 0.1%
 
 
 
Banks - 0.1%
 
 
 
HDFC Bank Ltd ADR
 
422,001
13,440,732
Financial Services - 0.0%
 
 
 
Jio Financial Services Ltd
 
620,946
1,742,417
TOTAL FINANCIALS
 
 
15,183,149
Industrials - 0.0%
 
 
 
Air Freight & Logistics - 0.0%
 
 
 
Delhivery Ltd (c)
 
486,000
2,314,209
TOTAL INDIA
 
 
46,969,660
IRELAND - 0.1%
 
 
 
Health Care - 0.1%
 
 
 
Biotechnology - 0.0%
 
 
 
Prothena Corp PLC (c)
 
429,522
3,723,956
Pharmaceuticals - 0.1%
 
 
 
GH Research PLC (b)(c)
 
530,287
7,874,762
TOTAL IRELAND
 
 
11,598,718
ISRAEL - 0.0%
 
 
 
Consumer Staples - 0.0%
 
 
 
Personal Care Products - 0.0%
 
 
 
Oddity Tech Ltd Class A (b)(c)
 
187,694
2,209,159
Information Technology - 0.0%
 
 
 
Semiconductors & Semiconductor Equipment - 0.0%
 
 
 
Xsight Labs Ltd warrants 7/24/2032 (c)(d)(e)
 
107,673
149,665
TOTAL ISRAEL
 
 
2,358,824
ITALY - 0.0%
 
 
 
Industrials - 0.0%
 
 
 
Passenger Airlines - 0.0%
 
 
 
Ryanair Holdings PLC ADR
 
15,682
1,058,378
Information Technology - 0.0%
 
 
 
Software - 0.0%
 
 
 
Bending Spoons SpA Class C (d)(e)
 
16,400
1,466,933
TOTAL ITALY
 
 
2,525,311
JAPAN - 0.3%
 
 
 
Consumer Discretionary - 0.0%
 
 
 
Broadline Retail - 0.0%
 
 
 
Rakuten Group Inc (c)
 
127,237
674,702
Industrials - 0.1%
 
 
 
Machinery - 0.1%
 
 
 
Mitsubishi Heavy Industries Ltd
 
598,015
19,063,460
Information Technology - 0.2%
 
 
 
Semiconductors & Semiconductor Equipment - 0.2%
 
 
 
Allegro MicroSystems Inc (c)
 
176,968
6,454,023
Kioxia Holdings Corp (c)
 
355,058
48,223,227
TOTAL INFORMATION TECHNOLOGY
 
 
54,677,250
TOTAL JAPAN
 
 
74,415,412
KOREA (SOUTH) - 0.0%
 
 
 
Information Technology - 0.0%
 
 
 
Technology Hardware, Storage & Peripherals - 0.0%
 
 
 
Samsung Electronics Co Ltd
 
73,225
11,008,564
MEXICO - 0.0%
 
 
 
Consumer Staples - 0.0%
 
 
 
Consumer Staples Distribution & Retail - 0.0%
 
 
 
BBB Foods Inc Class A (c)
 
274,868
10,018,939
NETHERLANDS - 0.6%
 
 
 
Health Care - 0.6%
 
 
 
Biotechnology - 0.6%
 
 
 
Argenx SE ADR (c)
 
175,138
134,316,835
Pharmaceuticals - 0.0%
 
 
 
Pharvaris NV (c)
 
369,852
10,500,098
TOTAL HEALTH CARE
 
 
144,816,933
Information Technology - 0.0%
 
 
 
Semiconductors & Semiconductor Equipment - 0.0%
 
 
 
ASML Holding NV depository receipt
 
2,262
3,281,167
TOTAL NETHERLANDS
 
 
148,098,100
POLAND - 0.0%
 
 
 
Consumer Discretionary - 0.0%
 
 
 
Specialty Retail - 0.0%
 
 
 
Modivo SA (b)(c)
 
161,403
5,009,471
RUSSIA - 0.0%
 
 
 
Consumer Discretionary - 0.0%
 
 
 
Broadline Retail - 0.0%
 
 
 
Ozon Holdings PLC ADR (b)(c)(d)
 
3,500
0
SWITZERLAND - 0.6%
 
 
 
Consumer Discretionary - 0.5%
 
 
 
Textiles, Apparel & Luxury Goods - 0.5%
 
 
 
On Holding AG Class A (c)
 
2,201,256
102,314,379
Health Care - 0.1%
 
 
 
Biotechnology - 0.1%
 
 
 
CRISPR Therapeutics AG (b)(c)
 
170,024
10,225,244
Idorsia Ltd (c)
 
1,374,043
6,996,655
 
 
 
17,221,899
Pharmaceuticals - 0.0%
 
 
 
Galderma Group AG
 
78,117
14,741,460
TOTAL HEALTH CARE
 
 
31,963,359
Information Technology - 0.0%
 
 
 
Electronic Equipment, Instruments & Components - 0.0%
 
 
 
TE Connectivity PLC
 
3,117
717,378
TOTAL SWITZERLAND
 
 
134,995,116
TAIWAN - 0.3%
 
 
 
Information Technology - 0.3%
 
 
 
Semiconductors & Semiconductor Equipment - 0.3%
 
 
 
Silicon Motion Technology Corp ADR
 
41,087
5,309,673
Taiwan Semiconductor Manufacturing Co Ltd ADR
 
157,728
59,081,754
 
 
 
 
TOTAL TAIWAN
 
 
64,391,427
UNITED KINGDOM - 0.1%
 
 
 
Consumer Staples - 0.0%
 
 
 
Personal Care Products - 0.0%
 
 
 
Unilever PLC ADR
 
2,600
191,750
Tobacco - 0.0%
 
 
 
British American Tobacco PLC ADR
 
37,100
2,324,315
TOTAL CONSUMER STAPLES
 
 
2,516,065
Financials - 0.0%
 
 
 
Capital Markets - 0.0%
 
 
 
3i Group PLC
 
40,526
1,810,535
Financial Services - 0.0%
 
 
 
Revolut Group Holdings Ltd (c)(d)(e)
 
4,668
6,549,577
TOTAL FINANCIALS
 
 
8,360,112
Health Care - 0.1%
 
 
 
Biotechnology - 0.1%
 
 
 
Immunocore Holdings PLC ADR (c)
 
351,286
11,346,538
TOTAL UNITED KINGDOM
 
 
22,222,715
UNITED STATES - 91.9%
 
 
 
Communication Services - 14.1%
 
 
 
Diversified Telecommunication Services - 0.1%
 
 
 
Comcast Corp Class A
 
48,109
1,489,454
Lumen Technologies Inc (c)
 
2,090,662
14,864,607
 
 
 
16,354,061
Entertainment - 1.4%
 
 
 
Netflix Inc (c)
 
2,676,797
257,614,943
ROBLOX Corp Class A (c)
 
706,282
48,493,322
Roku Inc Class A (c)
 
102,114
10,049,039
Spotify Technology SA (c)
 
22,807
11,744,237
Walt Disney Co/The
 
192
20,359
 
 
 
327,921,900
Interactive Media & Services - 12.4%
 
 
 
Alphabet Inc Class A
 
3,917,712
1,221,385,894
Alphabet Inc Class C
 
1,653,331
514,896,873
Epic Games Inc (c)(d)(e)
 
5,000
2,552,050
Meta Platforms Inc Class A
 
1,729,955
1,121,322,233
Reddit Inc Class A (c)
 
83,178
12,128,184
Reddit Inc Class B (c)
 
51,402
7,494,926
Snap Inc Class A (c)
 
2,059
10,727
 
 
 
2,879,790,887
Media - 0.0%
 
 
 
Trade Desk Inc (The) Class A (c)
 
25,935
617,772
Versant Media Group Inc Class A
 
1,924
64,107
 
 
 
681,879
Wireless Telecommunication Services - 0.2%
 
 
 
T-Mobile US Inc
 
236,268
51,291,420
TOTAL COMMUNICATION SERVICES
 
 
3,276,040,147
Consumer Discretionary - 10.8%
 
 
 
Automobiles - 1.9%
 
 
 
Rad Power Bikes Inc (c)(d)(e)
 
171,416
2
Rad Power Bikes Inc warrants 10/6/2033 (c)(d)(e)
 
280,502
3
Rivian Automotive Inc Class A (b)(c)
 
323,501
4,959,270
Tesla Inc (c)
 
1,077,983
433,898,937
 
 
 
438,858,212
Broadline Retail - 5.0%
 
 
 
Amazon.com Inc (c)
 
5,145,675
1,080,591,751
Ollie's Bargain Outlet Holdings Inc (c)
 
639,122
68,449,966
 
 
 
1,149,041,717
Hotels, Restaurants & Leisure - 0.9%
 
 
 
Airbnb Inc Class A (c)
 
70,375
9,508,366
Black Rock Coffee Bar Inc Class A
 
89,108
1,188,701
Booking Holdings Inc
 
12,587
53,360,699
Brinker International Inc (c)
 
203,117
30,101,939
Cava Group Inc (b)(c)
 
64,624
5,329,541
Chipotle Mexican Grill Inc (c)
 
545,199
20,292,307
DoorDash Inc Class A (c)
 
72,406
12,777,487
Dutch Bros Inc Class A (c)
 
50,136
2,687,791
Expedia Group Inc Class A
 
2,101
453,165
Hyatt Hotels Corp Class A (b)
 
6,700
1,082,050
Marriott International Inc/MD Class A1
 
98,417
33,632,042
McDonald's Corp
 
9,021
3,076,702
Shake Shack Inc Class A (c)
 
25,872
2,483,971
Starbucks Corp
 
222,123
21,772,496
Viking Holdings Ltd (c)
 
72,173
5,630,937
Wingstop Inc
 
17,869
4,637,184
Yum! Brands Inc
 
16,300
2,741,008
 
 
 
210,756,386
Household Durables - 0.4%
 
 
 
DR Horton Inc
 
34,999
5,613,490
Garmin Ltd
 
125,651
31,768,342
Lennar Corp Class A
 
46,557
5,324,258
SharkNinja Inc (c)
 
285,516
35,081,351
Somnigroup International Inc
 
206,118
18,449,622
Toll Brothers Inc
 
47,486
7,466,699
 
 
 
103,703,762
Leisure Products - 0.0%
 
 
 
Peloton Interactive Inc Class A (c)
 
223,284
897,602
Specialty Retail - 2.1%
 
 
 
Carvana Co Class A (c)
 
79,282
26,492,873
Dick's Sporting Goods Inc
 
137,770
28,054,105
Fanatics Inc Class A (c)(d)(e)
 
204,775
17,883,001
Floor & Decor Holdings Inc Class A (c)
 
62,490
4,317,434
Home Depot Inc/The
 
329,818
125,568,309
Lowe's Cos Inc
 
105,631
27,946,794
Revolve Group Inc Class A (c)
 
645,602
16,243,346
RH (c)
 
18,147
3,007,139
Ross Stores Inc
 
55,452
11,403,149
TJX Cos Inc/The
 
763,891
123,490,619
Wayfair Inc Class A (c)
 
1,285,496
98,121,910
 
 
 
482,528,679
Textiles, Apparel & Luxury Goods - 0.5%
 
 
 
Deckers Outdoor Corp (c)
 
529,094
62,046,853
Lululemon Athletica Inc (c)
 
183,784
34,031,283
NIKE Inc Class B
 
285,049
17,724,347
VF Corp
 
172,045
3,341,114
 
 
 
117,143,597
TOTAL CONSUMER DISCRETIONARY
 
 
2,502,929,955
Consumer Staples - 2.4%
 
 
 
Beverages - 0.8%
 
 
 
Celsius Holdings Inc (c)
 
83,063
4,453,007
Coca-Cola Co/The
 
1,572,604
128,261,582
Constellation Brands Inc Class A
 
4
631
Keurig Dr Pepper Inc
 
620,953
18,802,457
Monster Beverage Corp (c)
 
198,109
16,898,698
PepsiCo Inc
 
81,871
13,896,784
 
 
 
182,313,159
Consumer Staples Distribution & Retail - 0.6%
 
 
 
Costco Wholesale Corp
 
105,963
107,106,342
Kroger Co/The
 
124,356
8,486,053
Maplebear Inc (c)
 
23,736
890,337
Sprouts Farmers Market Inc (c)
 
60,230
4,449,190
Target Corp
 
56,851
6,469,075
Walmart Inc
 
110,713
14,165,728
 
 
 
141,566,725
Food Products - 0.1%
 
 
 
Bunge Global SA
 
43,260
5,219,318
Hershey Co/The
 
29,113
6,878,820
Mondelez International Inc
 
114,748
7,066,182
 
 
 
19,164,320
Household Products - 0.1%
 
 
 
Church & Dwight Co Inc
 
13,804
1,447,487
Clorox Co/The
 
7,647
972,393
Colgate-Palmolive Co
 
97,296
9,645,925
Procter & Gamble Co/The
 
81,747
13,668,099
 
 
 
25,733,904
Personal Care Products - 0.0%
 
 
 
Beauty Health Co/The (c)
 
365,143
379,749
Beauty Health Co/The Class A (b)(c)
 
1,259,172
1,309,539
Kenvue Inc
 
232,560
4,446,547
 
 
 
6,135,835
Tobacco - 0.8%
 
 
 
JUUL Labs Inc Class A (c)(d)(e)
 
4,278,644
8,471,715
Philip Morris International Inc
 
941,291
175,861,398
 
 
 
184,333,113
TOTAL CONSUMER STAPLES
 
 
559,247,056
Energy - 0.3%
 
 
 
Energy Equipment & Services - 0.1%
 
 
 
Baker Hughes Co Class A
 
188,306
12,288,850
Halliburton Co
 
135,079
4,862,844
 
 
 
17,151,694
Oil, Gas & Consumable Fuels - 0.2%
 
 
 
EOG Resources Inc
 
8,114
1,006,785
EQT Corp
 
229,926
14,122,055
Exxon Mobil Corp
 
19,300
2,943,250
Range Resources Corp
 
428,397
17,684,228
Valero Energy Corp
 
61,892
12,665,579
 
 
 
48,421,897
TOTAL ENERGY
 
 
65,573,591
Financials - 3.0%
 
 
 
Banks - 0.5%
 
 
 
Bank of America Corp
 
803,013
40,014,138
JPMorgan Chase & Co
 
127,107
38,170,232
US Bancorp
 
104,301
5,701,092
Wells Fargo & Co
 
338,517
27,572,210
 
 
 
111,457,672
Capital Markets - 0.5%
 
 
 
Blackrock Inc
 
26,577
28,257,464
Coinbase Global Inc Class A (c)
 
30
5,275
Goldman Sachs Group Inc/The
 
32,719
28,124,271
Robinhood Markets Inc Class A (c)
 
759,569
57,613,309
 
 
 
114,000,319
Consumer Finance - 0.1%
 
 
 
American Express Co
 
64,892
20,045,139
Figure Technology Solutions Inc Class A (b)
 
44,129
1,115,581
 
 
 
21,160,720
Financial Services - 1.9%
 
 
 
Block Inc Class A (c)
 
36,128
2,301,354
Mastercard Inc Class A
 
360,088
186,241,114
PayPal Holdings Inc
 
132,500
6,122,825
Perceptive Capital Solutions Corp (d)(e)(h)
 
124,847
1,248,470
Toast Inc Class A (c)
 
505,111
13,794,581
Visa Inc Class A
 
732,018
234,348,243
 
 
 
444,056,587
TOTAL FINANCIALS
 
 
690,675,298
Health Care - 10.6%
 
 
 
Biotechnology - 6.3%
 
 
 
AbbVie Inc
 
128,917
29,919,057
Absci Corp (b)(c)
 
2,233,380
6,119,461
Akouos Inc (c)(d)
 
338,256
64,268
Alnylam Pharmaceuticals Inc (c)
 
366,500
122,015,180
Amgen Inc
 
119,712
46,467,410
Antares Therapeutics Inc (d)
 
49,923
40,936
Apogee Therapeutics Inc (c)
 
511,830
35,828,100
ArriVent Biopharma Inc (c)
 
91,513
2,102,054
Arrowhead Pharmaceuticals Inc (c)
 
587,013
37,140,313
aTyr Pharma Inc (b)(c)
 
1,358,052
1,303,458
Beam Therapeutics Inc (c)
 
925,200
26,331,192
BeOne Medicines Ltd ADR (c)
 
177,140
56,151,609
Biogen Inc (c)
 
39,665
7,608,540
Biohaven Ltd (c)
 
45,021
518,642
Biomea Fusion Inc (b)(c)
 
918,983
1,259,007
Biomea Fusion Inc warrants 12/20/2026 (c)
 
235,800
9,165
Boundless Bio Inc (c)
 
229,453
266,165
CAMP4 Therapeutics Corp (e)
 
125,157
561,955
CAMP4 Therapeutics Corp (c)
 
110,942
498,130
Candel Therapeutics Inc (c)
 
504,643
2,649,376
Caris Life Sciences Inc (c)
 
336,115
6,769,356
Cibus Inc Class A (c)
 
762,003
2,811,791
Crescent Biopharma Inc (c)(e)
 
186,117
2,250,155
Crescent Biopharma Inc (c)
 
104,507
1,263,489
Day One Biopharmaceuticals Inc (c)
 
322,846
3,422,168
Denali Therapeutics Inc (c)
 
419,009
8,874,611
Dianthus Therapeutics Inc (c)
 
332,899
18,372,696
Disc Medicine Inc (c)
 
9,915
660,537
Dyne Therapeutics Inc (c)
 
504,374
7,878,322
Eikon Therapeutics Inc (c)
 
123,500
1,701,830
Foghorn Therapeutics Inc (c)
 
507,544
2,882,850
Generate Biomedicines Inc (f)
 
313,646
3,967,622
Generate Biomedicines Inc
 
96,200
1,539,200
Ideaya Biosciences Inc (c)
 
1,255,428
40,424,782
Immuneering Corp (b)(c)
 
812,045
4,052,105
Immunome Inc (b)(c)
 
1,315,710
28,761,421
Immunovant Inc (c)
 
1,402,818
38,900,143
Insmed Inc (c)
 
143,406
21,414,818
Ionis Pharmaceuticals Inc (c)
 
2,332,125
189,251,944
Jade Biosciences Inc
 
303,679
4,503,560
Janux Therapeutics Inc (c)
 
1,231
16,753
Krystal Biotech Inc (c)
 
228,112
62,876,792
Kymera Therapeutics Inc (c)
 
581,361
53,107,327
Moderna Inc (c)
 
1,296,154
69,434,970
Natera Inc (c)
 
3,100
644,924
Nurix Therapeutics Inc (c)
 
163,715
2,614,529
Nuvalent Inc Class A (c)
 
376,617
38,396,103
Odyssey Therapeutics Inc warrants (c)(d)
 
526,342
615,820
ORIC Pharmaceuticals Inc (b)(c)
 
233,347
3,138,517
Oruka Therapeutics Inc (c)
 
122,037
4,199,293
Oruka Therapeutics Inc (c)(e)
 
102,303
3,520,246
Praxis Precision Medicines Inc (c)
 
30,727
10,347,317
Recursion Pharmaceuticals Inc Class A (b)(c)
 
458,049
1,681,040
Regeneron Pharmaceuticals Inc
 
28,464
22,249,455
Revolution Medicines Inc (c)
 
697,132
71,121,407
Roivant Sciences Ltd (c)
 
6,114,974
176,967,348
Sana Biotechnology Inc (b)(c)
 
3,146,614
13,247,245
Scholar Rock Holding Corp (c)
 
1,177,658
52,134,920
Sigilon Therapeutics Inc rights (c)(d)
 
8,716
76,526
Spyre Therapeutics Inc (c)
 
672,126
28,908,139
Summit Therapeutics Inc (b)(c)
 
720,947
11,960,511
Taysha Gene Therapies Inc (c)
 
1,388,818
6,291,346
Tectonic Therapeutic Inc (b)(c)
 
246,835
5,788,281
UNITY Biotechnology Inc warrants 8/22/2027 (c)(d)
 
712,537
6
Vaxcyte Inc (c)
 
196,961
12,160,372
Vera Therapeutics Inc Class A (c)
 
227,802
9,292,044
Vertex Pharmaceuticals Inc (c)
 
47,214
23,457,332
Viking Therapeutics Inc (c)
 
545
18,442
 
 
 
1,450,824,423
Health Care Equipment & Supplies - 0.6%
 
 
 
Abbott Laboratories
 
32,384
3,767,878
Blink Health LLC Class A1 (c)(d)(e)
 
85,627
2,982,388
Boston Scientific Corp (c)
 
109,897
8,445,584
Ceribell Inc (c)
 
68,872
1,285,840
Dexcom Inc (c)
 
86,831
6,376,000
GE HealthCare Technologies Inc
 
80,252
6,762,836
Intuitive Surgical Inc (c)
 
141,590
71,291,982
Medical Microinstruments Inc/Italy warrants 2/16/2031 (c)(d)(e)
 
3,611
45,679
Medline Inc Class A
 
298,735
14,192,900
Novocure Ltd (c)
 
1,750,856
23,934,202
PROCEPT BioRobotics Corp (b)(c)
 
12,013
272,575
Saluda Medical Inc (e)(f)
 
94,929
702,585
Saluda Medical Inc depository receipt
 
570,214
422,024
 
 
 
140,482,473
Health Care Providers & Services - 0.3%
 
 
 
Alignment Healthcare Inc (c)
 
327,355
6,291,763
Blue Marlin Therapeutics, Inc. (d)
 
243
15,187
Cardinal Health Inc
 
42,398
9,718,894
Conformal Medical Inc (d)(e)
 
341,860
23,930
Conformal Medical Inc (d)(e)
 
341,860
6,837
Conformal Medical Inc (d)(e)
 
341,860
3,419
Conformal Medical Inc (d)(e)
 
341,860
3
CVS Health Corp
 
73,688
5,887,671
Guardant Health Inc (c)
 
9,600
901,440
HCA Healthcare Inc
 
37,648
19,942,146
McKesson Corp
 
27,165
26,821,906
Omada Health Inc
 
251,029
3,082,636
Scorpion Therapeutics Inc (d)(e)
 
792,406
269,418
Scorpion Therapeutics Inc (d)(e)
 
792,406
8
Scorpion Therapeutics Inc rights (c)(d)(e)
 
792,406
649,773
 
 
 
73,615,031
Health Care Technology - 0.0%
 
 
 
HeartFlow Inc (b)
 
148,932
3,449,265
Prognomiq Inc (c)(d)(e)
 
30,664
5,213
Wugen Inc warrants 8/22/2035 (c)(d)(e)
 
91,361
156,227
 
 
 
3,610,705
Life Sciences Tools & Services - 0.2%
 
 
 
10X Genomics Inc Class A (c)
 
41,185
949,314
Danaher Corp
 
62,581
13,182,062
Repligen Corp (c)
 
5,888
757,962
Thermo Fisher Scientific Inc
 
56,001
29,182,681
 
 
 
44,072,019
Pharmaceuticals - 3.2%
 
 
 
Adimab LLC (c)(d)(e)(g)
 
196,899
2,085,161
Adimab LLC (c)(d)(e)(g)
 
196,899
925,425
Amylyx Pharmaceuticals Inc (c)
 
98,050
1,487,419
Atea Pharmaceuticals Inc (c)
 
1,227,803
5,746,118
Bristol-Myers Squibb Co
 
110,054
6,864,068
Crinetics Pharmaceuticals Inc (c)
 
164,946
6,779,281
Eli Lilly & Co
 
534,380
562,162,416
Harmony Biosciences Holdings Inc (c)
 
140,238
4,002,393
LENZ Therapeutics Inc (b)(c)
 
317,141
4,278,232
Lexicon Pharmaceuticals Inc (c)
 
4,331,248
6,366,935
Maze Therapeutics Inc (c)
 
27,656
1,260,837
Nektar Therapeutics (c)
 
285,515
19,694,825
Nuvation Bio Inc Class A (c)
 
4,804,432
28,394,193
Ocular Therapeutix Inc (c)
 
2,635,532
23,561,656
Optinose Inc (d)
 
120,082
1
Optinose Inc warrants 11/23/2027 (c)(d)
 
231,338
3
Pfizer Inc
 
21,698
599,950
Pfizer Inc rights (c)(d)
 
1,110,156
6,028,147
Rapport Therapeutics Inc (c)
 
630,615
18,306,753
Roche Holding AG non-voting shares
 
9,560
4,549,618
Roche Holding AG rights (c)(d)
 
1,208,256
2,017,787
Sienna Biopharmaceuticals Inc (c)(d)
 
375,146
4
Skyhawk Therapeutics Inc (c)(d)(e)
 
132,933
7,379,111
Skyhawk Therapeutics Inc rights 5/23/2028 (c)(d)
 
31,376
0
Structure Therapeutics Inc ADR (c)
 
65,902
4,150,508
Tarsus Pharmaceuticals Inc (c)
 
63,057
4,762,065
Trevi Therapeutics Inc (c)
 
94,600
1,127,632
VeraDermics Inc
 
168,211
7,712,474
WaVe Life Sciences Ltd (c)
 
476,323
6,635,179
 
 
 
736,878,191
TOTAL HEALTH CARE
 
 
2,449,482,842
Industrials - 4.3%
 
 
 
Aerospace & Defense - 2.2%
 
 
 
Anduril Industries Inc Class B (d)(e)
 
2,199
139,724
Anduril Industries Inc Class C (d)(e)
 
1
64
Beta Technologies Inc (f)
 
396,800
7,459,840
Beta Technologies Inc Class A (c)
 
263,034
4,945,039
Boeing Co (c)
 
150,484
34,239,625
GE Aerospace
 
242,543
83,012,767
Lockheed Martin Corp
 
2,400
1,579,392
Space Exploration Technologies Corp (c)(d)(e)
 
647,416
340,922,791
Space Exploration Technologies Corp Class C (c)(d)(e)
 
59,083
31,112,517
 
 
 
503,411,759
Air Freight & Logistics - 0.0%
 
 
 
United Parcel Service Inc Class B
 
64,631
7,494,611
Construction & Engineering - 0.2%
 
 
 
Comfort Systems USA Inc
 
13,777
19,692,431
Fluor Corp (c)
 
47,191
2,468,561
Quanta Services Inc
 
33,123
18,650,899
 
 
 
40,811,891
Electrical Equipment - 0.5%
 
 
 
Eaton Corp PLC
 
34,628
13,017,358
Emerson Electric Co
 
44,919
6,771,539
GE Vernova Inc
 
82,028
71,659,661
Vertiv Holdings Co Class A
 
96,465
24,587,964
 
 
 
116,036,522
Ground Transportation - 0.3%
 
 
 
Old Dominion Freight Line Inc
 
36,946
7,501,885
Uber Technologies Inc (c)
 
752,816
56,777,383
Union Pacific Corp
 
2,100
556,458
 
 
 
64,835,726
Industrial Conglomerates - 0.1%
 
 
 
3M Co
 
41,181
6,808,043
Honeywell International Inc
 
61,807
15,055,567
 
 
 
21,863,610
Machinery - 0.3%
 
 
 
Caterpillar Inc
 
64,464
47,885,793
Deere & Co
 
22,864
14,397,689
Illinois Tool Works Inc
 
42,777
12,432,280
 
 
 
74,715,762
Passenger Airlines - 0.7%
 
 
 
Alaska Air Group Inc (c)
 
151,023
7,792,787
Delta Air Lines Inc
 
597,922
39,283,475
JetBlue Airways Corp (c)
 
375,800
2,081,932
Southwest Airlines Co
 
722,734
35,601,877
United Airlines Holdings Inc (c)
 
733,957
78,019,629
 
 
 
162,779,700
Trading Companies & Distributors - 0.0%
 
 
 
EquipmentShare.com Inc Class A (c)
 
69,700
2,022,694
TOTAL INDUSTRIALS
 
 
993,972,275
Information Technology - 45.9%
 
 
 
Communications Equipment - 3.7%
 
 
 
Arista Networks Inc (c)
 
257,394
34,362,098
Ciena Corp (c)
 
1,943,031
677,534,910
Lumentum Holdings Inc (c)
 
201,016
140,894,125
 
 
 
852,791,133
Electronic Equipment, Instruments & Components - 1.2%
 
 
 
Coherent Corp (c)
 
503,066
130,258,879
Corning Inc
 
1,025,547
154,221,758
 
 
 
284,480,637
IT Services - 0.6%
 
 
 
Akamai Technologies Inc (c)
 
94,648
9,312,417
Cloudflare Inc Class A (c)
 
684,587
117,879,036
Fastly Inc Class A (c)
 
267,900
5,122,248
IBM Corporation
 
29,469
7,078,748
Kyndryl Holdings Inc (c)
 
122,456
1,509,882
MongoDB Inc Class A (c)
 
8,312
2,730,243
Okta Inc Class A (c)
 
90,225
6,541,313
Snowflake Inc (c)
 
52,608
8,859,713
 
 
 
159,033,600
Semiconductors & Semiconductor Equipment - 21.1%
 
 
 
Advanced Micro Devices Inc (c)
 
322,834
64,634,595
Applied Materials Inc
 
82,252
30,622,420
ARM Holdings PLC ADR (c)
 
18,221
2,322,266
Astera Labs Inc (c)
 
692,361
82,273,258
Broadcom Inc
 
2,202,335
703,756,149
Cirrus Logic Inc (c)
 
3,423
483,054
First Solar Inc (c)
 
10,279
2,027,019
GlobalFoundries Inc (c)
 
222,657
10,587,340
Impinj Inc (c)
 
267,231
32,778,554
Intel Corp (c)
 
165,356
7,541,887
KLA Corp
 
50,471
76,945,563
Lam Research Corp
 
186,966
43,729,478
Marvell Technology Inc
 
817,919
66,815,803
Micron Technology Inc
 
43,104
17,774,796
Monolithic Power Systems Inc
 
20,632
23,577,012
NVIDIA Corp
 
19,857,825
3,518,608,013
ON Semiconductor Corp (c)
 
244,831
16,276,365
QUALCOMM Inc
 
111,954
15,937,771
SiTime Corp (c)
 
264,926
105,408,757
Teradyne Inc
 
142,929
45,741,568
Texas Instruments Inc
 
59,503
12,621,181
 
 
 
4,880,462,849
Software - 7.8%
 
 
 
Adobe Inc (c)
 
42,997
11,282,843
AppLovin Corp Class A (c)
 
350,899
152,560,358
Asapp Inc warrants 8/28/2028 (c)(d)(e)
 
351,555
175,778
Atlassian Corp Class A (c)
 
9,299
698,634
Autodesk Inc (c)
 
54,744
13,459,907
Canva Inc Class A (c)(d)(e)
 
3,905
5,259,215
Celestial AI Inc (d)(e)
 
414,165
12,425
Celestial AI Inc (d)(e)
 
414,165
4
Celestial AI Inc rights (c)(d)(e)
 
414,165
1,130,670
Celestial AI Inc rights (c)(d)(e)
 
414,165
869,747
Celestial AI Inc rights (c)(d)(e)
 
414,165
252,641
Circle Internet Group Inc Class A
 
12,996
1,084,386
Crowdstrike Holdings Inc Class A (c)
 
102,263
38,039,791
Datadog Inc Class A (c)
 
109,590
12,269,696
Figma Inc Class A
 
83,571
2,456,152
HubSpot Inc (c)
 
22,976
6,077,382
Intuit Inc
 
67,655
27,672,925
Microsoft Corp
 
2,578,361
1,012,625,499
Nutanix Inc Class A (c)
 
3,948,837
151,161,480
OpenAI Group Pbc Class A (d)(e)
 
5,300
3,677,670
Oracle Corp
 
1,522,781
221,412,357
Palantir Technologies Inc Class A (c)
 
168,274
23,085,510
Palo Alto Networks Inc (c)
 
26,829
3,995,375
Rubrik Inc Class A (c)
 
211,474
10,988,189
Salesforce Inc
 
28,552
5,561,644
Servicenow Inc (c)
 
386,605
41,757,206
Stripe LLC Class B (c)(d)(e)
 
38,500
2,425,500
Workday Inc Class A (c)
 
39,567
5,292,482
Zoom Communications Inc Class A (c)
 
410,009
30,316,065
Zscaler Inc (c)
 
139,123
20,449,690
 
 
 
1,806,051,221
Technology Hardware, Storage & Peripherals - 11.5%
 
 
 
Apple Inc
 
5,980,120
1,579,828,102
Pure Storage Inc Class A (c)
 
4,723,860
303,366,289
Sandisk Corp/DE (c)
 
1,153,188
732,689,528
Western Digital Corp
 
145,798
40,779,700
 
 
 
2,656,663,619
TOTAL INFORMATION TECHNOLOGY
 
 
10,639,483,059
Materials - 0.4%
 
 
 
Chemicals - 0.1%
 
 
 
Corteva Inc
 
88,294
7,074,115
Farmers Business Network Inc (c)(d)
 
9,829
3,833
Farmers Business Network Inc warrants 9/27/2033 (c)(d)(e)
 
993,920
616,231
Mosaic Co/The
 
111,520
3,104,717
Solstice Advanced Materials Inc
 
14,783
1,160,613
 
 
 
11,959,509
Construction Materials - 0.0%
 
 
 
James Hardie Industries PLC (c)
 
124,081
3,021,372
Containers & Packaging - 0.0%
 
 
 
Avery Dennison Corp
 
9,200
1,806,420
Smurfit Westrock PLC
 
7,500
352,575
 
 
 
2,158,995
Metals & Mining - 0.3%
 
 
 
Freeport-McMoRan Inc
 
1,039,784
70,788,495
TOTAL MATERIALS
 
 
87,928,371
Real Estate - 0.1%
 
 
 
Health Care REITs - 0.0%
 
 
 
Welltower Inc
 
50,579
10,475,922
Real Estate Management & Development - 0.0%
 
 
 
CBRE Group Inc Class A (c)
 
48,980
7,232,386
Specialized REITs - 0.1%
 
 
 
American Tower Corp
 
68,150
13,075,259
Equinix Inc
 
5,360
5,222,034
 
 
 
18,297,293
TOTAL REAL ESTATE
 
 
36,005,601
TOTAL UNITED STATES
 
 
21,301,338,195
 
TOTAL COMMON STOCKS
 (Cost $10,237,110,016)
 
 
 
22,228,703,916
 
 
 
 
Convertible Corporate Bonds - 0.1%
 
 
Principal
Amount (a)
 
Value ($)
 
UNITED STATES - 0.1%
 
 
 
Consumer Discretionary - 0.1%
 
 
 
Automobiles - 0.1%
 
 
 
Neutron Holdings Inc 4% 5/22/2027 (d)(e)
 
310,600
1,330,952
Neutron Holdings Inc 4% 6/12/2027 (d)(e)
 
82,200
352,235
Neutron Holdings Inc 8% 10/29/2026 (d)(e)(j)
 
2,430,728
4,212,938
TOTAL CONSUMER DISCRETIONARY
 
 
5,896,125
Financials - 0.0%
 
 
 
Financial Services - 0.0%
 
 
 
Tenstorrent Holdings Inc 15% 12/31/2026 (d)(e)
 
1,579,300
1,578,668
Health Care - 0.0%
 
 
 
Health Care Equipment & Supplies - 0.0%
 
 
 
Kardium Inc/US 10% 12/31/2026 (d)(e)
 
899,842
1,036,438
Health Care Technology - 0.0%
 
 
 
Wugen Inc 0% 12/31/2199 (d)(e)(i)
 
515,072
537,066
Pharmaceuticals - 0.0%
 
 
 
Galvanize Therapeutics 10% 2/28/2027 (d)(e)
 
576,493
753,303
TOTAL HEALTH CARE
 
 
2,326,807
Information Technology - 0.0%
 
 
 
Electronic Equipment, Instruments & Components - 0.0%
 
 
 
Enevate Corp 10% 5/12/2199 (d)(e)
 
11,723
2,824
Software - 0.0%
 
 
 
Evozyne Inc 6% 9/13/2028 pay-in-kind (d)(e)
 
1,705,422
2,018,367
TOTAL INFORMATION TECHNOLOGY
 
 
2,021,191
Materials - 0.0%
 
 
 
Chemicals - 0.0%
 
 
 
Farmers Business Network Inc 15% 12/31/2199 (d)(e)
 
1,314,459
627,654
TOTAL UNITED STATES
 
 
12,450,445
 
TOTAL CONVERTIBLE CORPORATE BONDS
 (Cost $9,696,546)
 
 
 
12,450,445
 
 
 
 
Convertible Preferred Stocks - 4.0%
 
 
Shares
Value ($)
 
CANADA - 0.0%
 
 
 
Health Care - 0.0%
 
 
 
Biotechnology - 0.0%
 
 
 
Deep Genomics Inc Series C (c)(d)(e)
 
155,443
1,800,030
Information Technology - 0.0%
 
 
 
Software - 0.0%
 
 
 
Taalas Inc Series B (c)(d)(e)
 
30,000
2,209,800
TOTAL CANADA
 
 
4,009,830
CHINA - 0.1%
 
 
 
Communication Services - 0.1%
 
 
 
Interactive Media & Services - 0.1%
 
 
 
Bytedance Ltd Series E1 (c)(d)(e)
 
49,039
12,036,623
ESTONIA - 0.0%
 
 
 
Information Technology - 0.0%
 
 
 
Software - 0.0%
 
 
 
Bolt Technology OU Series E (c)(d)(e)
 
17,815
3,516,858
FINLAND - 0.2%
 
 
 
Health Care - 0.2%
 
 
 
Health Care Technology - 0.2%
 
 
 
Oura Health Oy Series D (c)(d)(e)
 
325,076
19,790,627
Oura Health Oy Series E (d)(e)
 
570,150
34,710,732
 
 
 
 
TOTAL FINLAND
 
 
54,501,359
FRANCE - 0.0%
 
 
 
Health Care - 0.0%
 
 
 
Health Care Technology - 0.0%
 
 
 
DNA Script SAS Series B (c)(d)(e)
 
6
107
DNA Script SAS Series C (c)(d)(e)
 
2,549
447,719
 
 
 
 
TOTAL FRANCE
 
 
447,826
INDIA - 0.0%
 
 
 
Consumer Discretionary - 0.0%
 
 
 
Specialty Retail - 0.0%
 
 
 
Valuedrive Technologies Pvt Ltd Series A (e)(h)
 
168
221,009
Valuedrive Technologies Pvt Ltd Series B (e)(h)
 
338
444,651
Valuedrive Technologies Pvt Ltd Series G (d)(e)
 
2,167,800
900,064
 
 
 
 
TOTAL INDIA
 
 
1,565,724
ISRAEL - 0.0%
 
 
 
Health Care - 0.0%
 
 
 
Health Care Equipment & Supplies - 0.0%
 
 
 
InSightec Ltd Series G (c)(d)(e)
 
2,718,923
2,039,192
Industrials - 0.0%
 
 
 
Electrical Equipment - 0.0%
 
 
 
Element Labs Inc Series A (c)(d)(e)
 
166,900
1,440,347
Element Labs Inc Series B (d)(e)
 
155,700
1,483,822
TOTAL INDUSTRIALS
 
 
2,924,169
Information Technology - 0.0%
 
 
 
Semiconductors & Semiconductor Equipment - 0.0%
 
 
 
Xsight Labs Ltd Series D (c)(d)(e)
 
122,201
183,301
Xsight Labs Ltd Series F (d)(e)
 
358,909
1,507,418
TOTAL INFORMATION TECHNOLOGY
 
 
1,690,719
TOTAL ISRAEL
 
 
6,654,080
UNITED KINGDOM - 0.0%
 
 
 
Health Care - 0.0%
 
 
 
Biotechnology - 0.0%
 
 
 
Quell Therapeutics Ltd Series B (c)(d)(e)
 
822,639
1,892,070
Information Technology - 0.0%
 
 
 
Software - 0.0%
 
 
 
NScale Global Holdings Ltd Series B (d)(e)
 
5,300
6,838,855
TOTAL UNITED KINGDOM
 
 
8,730,925
UNITED STATES - 3.7%
 
 
 
Consumer Discretionary - 0.0%
 
 
 
Automobiles - 0.0%
 
 
 
Rad Power Bikes Inc Series A (c)(d)(e)
 
22,348
0
Rad Power Bikes Inc Series C (c)(d)(e)
 
87,936
0
Rad Power Bikes Inc Series D (c)(d)(e)
 
219,600
2
Waymo LLC Series A2 (c)(d)(e)
 
6,592
1,112,268
Waymo LLC Series C2 (c)(d)(e)
 
18,943
3,112,714
 
 
 
4,224,984
Hotels, Restaurants & Leisure - 0.0%
 
 
 
Discord Inc Series I (c)(d)(e)
 
14,000
343,672
Textiles, Apparel & Luxury Goods - 0.0%
 
 
 
Laronde Inc Series B (c)(d)(e)
 
81,282
1,732,119
TOTAL CONSUMER DISCRETIONARY
 
 
6,300,775
Consumer Staples - 0.0%
 
 
 
Consumer Staples Distribution & Retail - 0.0%
 
 
 
GoBrands Inc Series G (c)(d)(e)
 
19,907
791,104
GoBrands Inc Series H (c)(d)(e)
 
20,720
1,057,342
 
 
 
1,848,446
Food Products - 0.0%
 
 
 
AgBiome LLC Series D (c)(d)(e)
 
511,821
5,118
TOTAL CONSUMER STAPLES
 
 
1,853,564
Financials - 0.1%
 
 
 
Financial Services - 0.1%
 
 
 
Akeana Series C (c)(d)(e)
 
113,800
1,408,844
Paragon Biosciences Emalex Capital Inc Series C (c)(d)(e)
 
109,967
1,024,893
Paragon Biosciences Emalex Capital Inc Series D-3 (d)(e)
 
60,730
624,304
Paragon Biosciences Emalex Capital Inc Series D1 (c)(d)(e)
 
211,815
1,982,589
Paragon Biosciences Emalex Capital Inc Series D2 (c)(d)(e)
 
15,557
136,279
Tenstorrent Holdings Inc Series C1 (c)(d)(e)
 
32,710
1,989,422
Tenstorrent Holdings Inc Series D1 (c)(d)(e)
 
81,867
5,307,438
Tenstorrent Holdings Inc Series D2 (c)(d)(e)
 
15,346
956,669
TOTAL FINANCIALS
 
 
13,430,438
Health Care - 0.4%
 
 
 
Biotechnology - 0.2%
 
 
 
Altos Labs Inc Series B (c)(d)(e)
 
124,464
3,114,089
Altos Labs Inc Series C (c)(d)(e)
 
52,694
1,318,404
Ankyra Therapeutics Series B (c)(d)(e)
 
329,325
1,824,461
Asimov Inc Series B (c)(d)(e)
 
19,920
514,534
Bright Peak Therapeutics Inc. Series B (c)(d)(e)
 
282,257
321,773
Bright Peak Therapeutics Inc. Series C (c)(d)(e)
 
1,110,268
988,139
Cardurion Pharmaceuticals Inc Series B (c)(d)(e)
 
449,156
2,389,510
Castle Creek Biosciences Inc Series C (c)(d)(e)
 
582
148,514
Castle Creek Biosciences Inc Series D1 (c)(d)(e)
 
4,476
1,006,205
Castle Creek Biosciences Inc Series D2 (c)(d)(e)
 
1,254
251,515
CELLANOME Inc Series B (c)(d)(e)
 
400,974
2,987,256
City Therapeutics Inc Series A (c)(d)(e)
 
298,887
3,084,514
Cleerly Inc Series C (c)(d)(e)
 
294,888
3,691,998
Element Biosciences Inc Series B (c)(d)(e)
 
125,057
896,659
Element Biosciences Inc Series C (c)(d)(e)
 
114,255
1,277,371
Element Biosciences Inc Series D (c)(d)(e)
 
92,374
695,576
Element Biosciences Inc Series D1 (c)(d)(e)
 
92,374
695,576
ElevateBio LLC Series C (c)(d)(e)
 
247,600
502,628
Genesis Therapeutics Inc Series D (c)(d)(e)
 
583,881
3,059,536
Kardigan Inc Series B (d)(e)
 
142,848
3,052,662
LifeMine Therapeutics Inc Series C (c)(d)(e)
 
1,759,782
2,076,543
National Resilience LLC Series B (c)(d)(e)
 
182,315
723,791
National Resilience LLC Series C (c)(d)(e)
 
74,748
547,902
Neurona Therapeutics Inc Series F (d)(e)
 
1,010,300
2,374,205
Odyssey Therapeutics Inc Series B (c)(d)(e)
 
458,024
627,493
Odyssey Therapeutics Inc Series C (c)(d)(e)
 
442,442
588,447
Odyssey Therapeutics Inc Series D (d)(e)
 
1,754,475
2,561,534
Parabilis Medicines Inc Series D (c)(d)(e)
 
272,597
2,014,492
Parabilis Medicines Inc Series E (c)(d)(e)
 
202,540
1,103,843
Parabilis Medicines Inc Series F (d)(e)
 
490,784
3,028,137
Sonoma Biotherapeutics Inc Series B (c)(d)(e)
 
587,934
946,574
Sonoma Biotherapeutics Inc Series B1 (c)(d)(e)
 
313,559
617,711
T-Knife Therapeutics Inc Series B (c)(d)(e)
 
241,456
169,019
Treeline Biosciences Series A (c)(d)(e)
 
283,817
2,398,254
Treeline Biosciences Series A1 (c)(d)(e)
 
151,334
1,309,039
Triveni Bio Inc Series B (c)(d)(e)
 
2,078,466
2,369,451
 
 
 
55,277,355
Health Care Equipment & Supplies - 0.1%
 
 
 
Blink Health LLC Series C (c)(d)(e)
 
145,007
5,050,594
Blink Health LLC Series C1 (c)(d)(e)
 
56,458
1,966,432
Blink Health LLC Series D (c)(d)(e)
 
62,396
2,173,253
Kardium Inc/US Series D-6 (d)(e)
 
1,517,942
1,396,507
Kardium Inc/US Series D-6 (d)(e)
 
1,087,032
1,250,087
Kardium Inc/US Series D-7 (d)(e)
 
3,576,917
2,038,843
Kardium Inc/US Series D-7 (d)(e)
 
782,873
446,238
Kardium Inc/US Series D-7 (d)(e)
 
162,879
92,840
Medical Microinstruments Inc/Italy Series C (c)(d)(e)
 
81,214
2,723,105
 
 
 
17,137,899
Health Care Providers & Services - 0.0%
 
 
 
Freenome Holdings Inc Series C (c)(d)(e)
 
141,369
460,863
Freenome Holdings Inc Series D (c)(d)(e)
 
125,665
409,668
 
 
 
870,531
Health Care Technology - 0.0%
 
 
 
Aledade Inc Series B1 (c)(d)(e)
 
26,096
705,636
Aledade Inc Series E1 (c)(d)(e)
 
21,357
577,493
Candid Therapeutics Series B (c)(d)(e)
 
1,469,416
1,777,993
Wugen Inc Series B (c)(d)(e)
 
121,894
188,936
Wugen Inc Series C (d)(e)
 
1,419,600
2,441,712
 
 
 
5,691,770
Pharmaceuticals - 0.1%
 
 
 
Galvanize Therapeutics Series B (c)(d)(e)
 
1,125,997
810,718
Galvanize Therapeutics Series C-1 (d)(e)
 
1,919,707
863,868
Kartos Therapeutics Inc Series C (c)(d)(e)
 
472,772
2,751,533
Kartos Therapeutics Inc Series D (c)(d)(e)
 
128,671
748,865
Mentari Therapeutics Inc Series A (d)(e)
 
593,950
920,622
Mirador Therapeutics Inc Series A (c)(d)(e)
 
957,764
3,409,640
Mirador Therapeutics Inc Series B (d)(e)
 
1,424,532
5,156,806
 
 
 
14,662,052
TOTAL HEALTH CARE
 
 
93,639,607
Industrials - 2.0%
 
 
 
Aerospace & Defense - 1.9%
 
 
 
Anduril Industries Inc Series F (c)(d)(e)
 
111,962
7,114,065
Anduril Industries Inc Series G (d)(e)
 
20,700
1,315,278
Space Exploration Technologies Corp Series G (c)(d)(e)
 
7,729
40,700,141
Space Exploration Technologies Corp Series J (c)(d)(e)
 
52,171
274,727,270
Space Exploration Technologies Corp Series N (c)(d)(e)
 
19,900
104,791,410
 
 
 
428,648,164
Air Freight & Logistics - 0.1%
 
 
 
Zipline International Inc Series G (c)(d)(e)
 
74,075
4,167,460
Zipline International Inc Series H (d)(e)
 
88,900
5,001,514
 
 
 
9,168,974
Electrical Equipment - 0.0%
 
 
 
Empower Semiconductor Inc Series D (d)(e)
 
314,200
1,957,466
TOTAL INDUSTRIALS
 
 
439,774,604
Information Technology - 1.2%
 
 
 
Electronic Equipment, Instruments & Components - 0.6%
 
 
 
Cerebras Systems Inc Series G (d)(e)
 
763,800
67,993,476
Enevate Corp Series E (c)(d)(e)
 
754,820
45,289
Menlo Microsystems Inc Series C (c)(d)(e)
 
993,699
546,534
Vast Data Ltd Series A (c)(d)(e)
 
107,503
6,366,328
Vast Data Ltd Series A1 (c)(d)(e)
 
264,598
15,669,494
Vast Data Ltd Series A2 (c)(d)(e)
 
304,373
18,024,970
Vast Data Ltd Series B (c)(d)(e)
 
242,193
14,342,669
Vast Data Ltd Series C (c)(d)(e)
 
7,060
418,093
Vast Data Ltd Series E (c)(d)(e)
 
231,432
13,705,403
 
 
 
137,112,256
Semiconductors & Semiconductor Equipment - 0.0%
 
 
 
Alif Semiconductor Series C (c)(d)(e)
 
43,034
1,235,506
Alif Semiconductor Series D (d)(e)
 
76,900
2,336,991
Danger Devices Inc Series B (d)(e)
 
1,177,500
1,071,524
Retym Inc Series C (c)(d)(e)
 
202,380
2,112,847
Retym Inc Series D (c)(d)(e)
 
50,206
552,768
SiMa Technologies Inc Series B (c)(d)(e)
 
299,482
1,958,613
SiMa Technologies Inc Series B1 (c)(d)(e)
 
167,848
1,273,966
 
 
 
10,542,215
Software - 0.5%
 
 
 
Anthropic PBC Series D (c)(d)(e)
 
100,142
27,410,868
Anthropic PBC Series E (c)(d)(e)
 
14,200
3,679,788
Anthropic PBC Series F (d)(e)
 
19,800
5,130,972
Asapp Inc Series D (c)(d)(e)
 
612,736
453,425
Canva Inc Series A2 (c)(d)(e)
 
268
360,939
Canvas Inc Series A (c)(d)(e)
 
1,477
1,989,209
Crusoe Energy Systems LLC Series D (c)(d)(e)
 
100,444
10,847,952
Crusoe Energy Systems LLC Series E (d)(e)
 
14,214
1,535,112
Databricks Inc Series G (c)(d)(e)
 
37,815
6,795,356
Databricks Inc Series H (c)(d)(e)
 
56,085
10,078,475
Databricks Inc Series I (c)(d)(e)
 
3,131
562,640
Databricks Inc Series J (c)(d)(e)
 
84,014
15,097,316
Databricks Inc Series K (d)(e)
 
6,300
1,132,110
Databricks Inc Series L (d)(e)
 
6,700
1,203,990
Density Ai Inc (d)(e)
 
713,183
1,062,643
Evozyne Inc Series A (c)(d)(e)
 
78,000
1,283,880
Evozyne Inc Series B (c)(d)(e)
 
95,720
1,622,454
Lyte Ai Inc Series B (c)(d)(e)
 
213,232
2,275,185
OpenAI Group Pbc Series A-3 (d)(e)
 
9,442
6,551,804
Physical Intelligence Inc Series B (d)(e)
 
12,400
3,366,476
Skyryse Inc Series B (c)(d)(e)
 
117,653
3,077,802
Skyryse Inc Series C (d)(e)
 
114,500
3,094,935
Skyryse Inc Series C-1 (d)(e)
 
18,658
489,213
Stripe LLC Series H (c)(d)(e)
 
14,400
907,200
 
 
 
110,009,744
Technology Hardware, Storage & Peripherals - 0.1%
 
 
 
Lightmatter Inc Series C1 (c)(d)(e)
 
136,712
7,454,905
Lightmatter Inc Series C2 (c)(d)(e)
 
21,474
1,203,188
Lightmatter Inc Series D (c)(d)(e)
 
133,986
9,609,477
 
 
 
18,267,570
TOTAL INFORMATION TECHNOLOGY
 
 
275,931,785
Materials - 0.0%
 
 
 
Chemicals - 0.0%
 
 
 
Farmers Business Network Inc Series G (c)(d)(e)
 
33,030
12,881
Manus Bio Inc Series One-5 (d)(e)
 
121,101
403,266
Manus Bio Inc Series One-6 (d)(e)
 
181,143
603,207
 
 
 
1,019,354
Metals & Mining - 0.0%
 
 
 
Diamond Foundry Inc Series C (c)(d)(e)
 
301,038
9,341,209
TOTAL MATERIALS
 
 
10,360,563
Utilities - 0.0%
 
 
 
Independent Power and Renewable Electricity Producers - 0.0%
 
 
 
Redwood Materials Series C (c)(d)(e)
 
20,469
977,191
Redwood Materials Series D (c)(d)(e)
 
7,960
380,010
Redwood Materials Series E (d)(e)
 
1,465
69,939
TOTAL UTILITIES
 
 
1,427,140
TOTAL UNITED STATES
 
 
842,718,476
 
TOTAL CONVERTIBLE PREFERRED STOCKS
 (Cost $418,659,957)
 
 
 
934,181,701
 
 
 
 
Preferred Securities - 0.0%
 
 
Principal
Amount (a)
 
Value ($)
 
CANADA - 0.0%
 
 
 
Information Technology - 0.0%
 
 
 
Software - 0.0%
 
 
 
Taalas Inc 0% (d)(e)(k)
 
2,520,461
2,507,859
UNITED STATES - 0.0%
 
 
 
Consumer Discretionary - 0.0%
 
 
 
Automobiles - 0.0%
 
 
 
Rad Power Bikes Inc 8% 12/31/2199 (d)(e)
 
280,502
63,372
Information Technology - 0.0%
 
 
 
Electronic Equipment, Instruments & Components - 0.0%
 
 
 
Enevate Corp 6% (d)(e)(k)
 
44,206
3,514
Semiconductors & Semiconductor Equipment - 0.0%
 
 
 
SiMa Technologies Inc 10% 12/31/2027 (d)(e)
 
498,596
662,075
SiMa Technologies Inc 7.5% 12/31/2027 (d)(e)
 
434,800
526,537
 
 
 
1,188,612
TOTAL INFORMATION TECHNOLOGY
 
 
1,192,126
TOTAL UNITED STATES
 
 
1,255,498
 
TOTAL PREFERRED SECURITIES
 (Cost $3,778,565)
 
 
 
3,763,357
 
 
 
 
Money Market Funds - 0.5%
 
 
Yield (%)
Shares
Value ($)
 
Fidelity Cash Central Fund (l)
 
3.70
5,627,363
5,628,488
Fidelity Securities Lending Cash Central Fund (l)(m)
 
3.69
115,708,871
115,720,442
 
TOTAL MONEY MARKET FUNDS
 (Cost $121,348,930)
 
 
 
121,348,930
 
 
 
 
 
 
TOTAL INVESTMENT IN SECURITIES - 100.5%
 (Cost $10,790,594,014)
 
 
 
23,300,448,349
NET OTHER ASSETS (LIABILITIES) - (0.5)%  
(122,456,695)
NET ASSETS - 100.0%
23,177,991,654
 
 
Legend
 
(a)
Amount is stated in United States dollars unless otherwise noted.
 
(b)
Security or a portion of the security is on loan at period end.
 
(c)
Non-income producing.
 
(d)
Level 3 security.
 
(e)
Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues).  At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $1,398,292,721 or 6.0% of net assets.
 
(f)
Security is subject to lock-up or market standoff agreement. Fair value is based on the unadjusted market price of the equivalent equity security. At the end of the period, the total value of unadjusted equity securities subject to contractual sale restrictions is $34,812,641 with varying restriction expiration dates. Under normal market conditions, there are no circumstances that could cause the restrictions to lapse.
 
(g)
Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes.
 
(h)
Security or a portion of the security purchased on a delayed delivery or when-issued basis.
 
(i)
Coupon rates for floating and adjustable rate securities reflect the rates in effect at period end.
 
(j)
Security initially issued at one coupon which converts to a higher coupon at a specified date. The rate shown is the rate at period end.
 
(k)
Security is perpetual in nature with no stated maturity date.
 
(l)
Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
 
(m)
Investment made with cash collateral received from securities on loan.
 
 
 
Additional information on each restricted holding is as follows:
Security
Acquisition Date
Acquisition Cost ($)
 
Adimab LLC
1/19/2021
7,455,144
 
 
 
Adimab LLC
1/19/2021
2,544,864
 
 
 
AgBiome LLC Series D
9/3/2021
2,852,725
 
 
 
Akeana Series C
1/23/2024
1,452,179
 
 
 
Aledade Inc Series B1
5/7/2021
999,234
 
 
 
Aledade Inc Series E1
5/20/2022
1,063,886
 
 
 
Alif Semiconductor Series C
3/8/2022
873,527
 
 
 
Alif Semiconductor Series D
4/11/2025
2,077,615
 
 
 
Altos Labs Inc Series B
7/22/2022
2,383,287
 
 
 
Altos Labs Inc Series C
3/15/2024
1,318,530
 
 
 
Anduril Industries Inc Class B
6/16/2025
89,901
 
 
 
Anduril Industries Inc Class C
6/16/2025
41
 
 
 
Anduril Industries Inc Series F
8/7/2024
2,433,673
 
 
 
Anduril Industries Inc Series G
4/17/2025
846,274
 
 
 
Ankyra Therapeutics Series B
8/26/2021
1,854,693
 
 
 
Anthropic PBC Series D
5/31/2024
3,004,712
 
 
 
Anthropic PBC Series E
2/14/2025
796,428
 
 
 
Anthropic PBC Series F
8/18/2025
2,791,158
 
 
 
Asapp Inc Series D
8/29/2023
2,366,080
 
 
 
Asapp Inc warrants 8/28/2028
8/29/2023
0
 
 
 
Asimov Inc Series B
10/29/2021
1,846,200
 
 
 
Bending Spoons SpA Class C
10/9/2025
1,446,968
 
 
 
Blink Health LLC Class A1
12/30/2020 - 6/17/2024
2,447,843
 
 
 
Blink Health LLC Series C
11/7/2019 - 7/14/2021
5,535,787
 
 
 
Blink Health LLC Series C1
7/15/2022 - 2/2/2024
2,193,318
 
 
 
Blink Health LLC Series D
6/17/2024 - 6/25/2024
2,620,632
 
 
 
Bolt Technology OU Series E
1/3/2022
4,628,275
 
 
 
Bright Peak Therapeutics Inc. Series B
5/14/2021
1,102,496
 
 
 
Bright Peak Therapeutics Inc. Series C
5/7/2024
1,258,489
 
 
 
Bytedance Ltd Series E1
11/18/2020
5,373,408
 
 
 
CAMP4 Therapeutics Corp
9/9/2025
191,490
 
 
 
Candid Therapeutics Series B
8/27/2024
1,763,299
 
 
 
Canva Inc Class A
3/18/2024 - 11/12/2025
5,382,217
 
 
 
Canva Inc Series A2
9/22/2023
285,865
 
 
 
Canvas Inc Series A
9/22/2023
1,575,458
 
 
 
Cardurion Pharmaceuticals Inc Series B
7/10/2024
2,199,786
 
 
 
Castle Creek Biosciences Inc Series C
12/9/2019
239,697
 
 
 
Castle Creek Biosciences Inc Series D1
4/19/2022
962,474
 
 
 
Castle Creek Biosciences Inc Series D2
6/28/2021
215,100
 
 
 
Celestial AI Inc
2/25/2025
0
 
 
 
Celestial AI Inc
2/25/2025
10,647
 
 
 
Celestial AI Inc rights
2/25/2025
662,284
 
 
 
Celestial AI Inc rights
2/25/2025
861,920
 
 
 
Celestial AI Inc rights
2/25/2025
193,298
 
 
 
CELLANOME Inc Series B
1/8/2024
3,003,295
 
 
 
Cerebras Systems Inc Series G
9/19/2025
27,674,307
 
 
 
City Therapeutics Inc Series A
4/17/2024
2,997,687
 
 
 
Cleerly Inc Series C
7/8/2022
3,473,958
 
 
 
Conformal Medical Inc
2/18/2026
23,930
 
 
 
Conformal Medical Inc
2/18/2026
3
 
 
 
Conformal Medical Inc
2/18/2026
3,419
 
 
 
Conformal Medical Inc
2/18/2026
6,837
 
 
 
Crescent Biopharma Inc
10/28/2024 - 12/4/2025
2,483,353
 
 
 
Crusoe Energy Systems LLC Series D
12/10/2024
2,930,137
 
 
 
Crusoe Energy Systems LLC Series E
10/8/2025
1,194,093
 
 
 
Danger Devices Inc Series B
3/5/2025
1,060,339
 
 
 
Databricks Inc Series G
2/1/2021
2,235,722
 
 
 
Databricks Inc Series H
8/31/2021
4,121,358
 
 
 
Databricks Inc Series I
9/14/2023
230,129
 
 
 
Databricks Inc Series J
12/17/2024
7,771,296
 
 
 
Databricks Inc Series K
9/8/2025
945,000
 
 
 
Databricks Inc Series L
12/18/2025
1,273,000
 
 
 
Deep Genomics Inc Series C
7/21/2021
2,254,110
 
 
 
Density Ai Inc
12/5/2025
1,062,632
 
 
 
Diamond Foundry Inc Series C
3/15/2021
7,224,912
 
 
 
Discord Inc Series I
9/15/2021
770,873
 
 
 
DNA Script SAS
12/17/2021
92,085
 
 
 
DNA Script SAS
12/17/2021
351,527
 
 
 
DNA Script SAS Series B
12/17/2021
4,804
 
 
 
DNA Script SAS Series C
10/1/2021
2,217,248
 
 
 
Element Biosciences Inc Series B
12/13/2019
655,373
 
 
 
Element Biosciences Inc Series C
6/21/2021
2,348,706
 
 
 
Element Biosciences Inc Series D
6/28/2024
724,517
 
 
 
Element Biosciences Inc Series D1
6/28/2024
724,517
 
 
 
Element Labs Inc Series A
2/11/2025
615,627
 
 
 
Element Labs Inc Series B
6/27/2025
1,366,875
 
 
 
ElevateBio LLC Series C
3/9/2021
1,038,681
 
 
 
Empower Semiconductor Inc Series D
6/27/2025
2,521,706
 
 
 
Enevate Corp 10% 5/12/2199
11/12/2024
11,723
 
 
 
Enevate Corp 6%
11/2/2023 - 10/31/2025
44,206
 
 
 
Enevate Corp Series E
1/29/2021
836,858
 
 
 
Epic Games Inc
7/13/2020 - 7/30/2020
2,875,000
 
 
 
Evozyne Inc 6% 9/13/2028 pay-in-kind
9/14/2023 - 12/31/2025
1,705,422
 
 
 
Evozyne Inc Series A
4/9/2021
1,752,660
 
 
 
Evozyne Inc Series B
9/14/2023
1,482,703
 
 
 
Fanatics Inc Class A
8/13/2020 - 10/24/2022
7,298,409
 
 
 
Farmers Business Network Inc 15% 12/31/2199
9/29/2023 - 9/25/2025
1,314,459
 
 
 
Farmers Business Network Inc Series G
9/15/2021
2,053,072
 
 
 
Farmers Business Network Inc warrants 9/27/2033
9/29/2023
1
 
 
 
Freenome Holdings Inc Series C
8/14/2020
934,916
 
 
 
Freenome Holdings Inc Series D
11/22/2021
947,803
 
 
 
Galvanize Therapeutics 10% 2/28/2027
7/7/2025
736,585
 
 
 
Galvanize Therapeutics Series B
3/29/2022
1,949,422
 
 
 
Galvanize Therapeutics Series C-1
7/7/2025
844,671
 
 
 
Genesis Therapeutics Inc Series D
8/10/2023
2,982,231
 
 
 
GoBrands Inc Series G
3/2/2021
4,971,122
 
 
 
GoBrands Inc Series H
7/22/2021
8,049,526
 
 
 
InSightec Ltd Series G
6/17/2024
2,413,860
 
 
 
JUUL Labs Inc Class A
2/23/2024 - 11/4/2025
5,626,179
 
 
 
Kardigan Inc Series B
10/9/2025
3,051,959
 
 
 
Kardium Inc/US 10% 12/31/2026
5/31/2024 - 12/31/2025
1,010,457
 
 
 
Kardium Inc/US Series D-6
12/30/2020
1,104,251
 
 
 
Kardium Inc/US Series D-6
12/30/2020
1,541,987
 
 
 
Kardium Inc/US Series D-7
5/31/2024 - 6/30/2025
1,611,099
 
 
 
Kardium Inc/US Series D-7
8/6/2024
25,338
 
 
 
Kardium Inc/US Series D-7
8/6/2024
380,030
 
 
 
Kartos Therapeutics Inc Series C
8/22/2023
2,672,580
 
 
 
Kartos Therapeutics Inc Series D
2/26/2025
727,377
 
 
 
Laronde Inc Series B
8/13/2021
2,275,896
 
 
 
LifeMine Therapeutics Inc Series C
2/15/2022
3,583,954
 
 
 
Lightmatter Inc Series C1
5/19/2023
2,249,842
 
 
 
Lightmatter Inc Series C2
12/18/2023
558,362
 
 
 
Lightmatter Inc Series D
10/11/2024
10,749,764
 
 
 
Lyte Ai Inc Series B
8/13/2024
2,705,082
 
 
 
Manus Bio Inc Series One-5
11/13/2020
1,270,263
 
 
 
Manus Bio Inc Series One-6
3/30/2021
1,900,058
 
 
 
Medical Microinstruments Inc/Italy Series C
2/16/2024
2,707,163
 
 
 
Medical Microinstruments Inc/Italy warrants 2/16/2031
2/16/2024
0
 
 
 
Menlo Microsystems Inc Series C
2/9/2022
1,317,148
 
 
 
Mentari Therapeutics Inc Series A
9/18/2025
815,077
 
 
 
Mirador Therapeutics Inc Series A
3/19/2024
2,873,292
 
 
 
Mirador Therapeutics Inc Series B
7/31/2025
4,700,956
 
 
 
National Resilience LLC Series B
12/1/2020
2,490,423
 
 
 
National Resilience LLC Series C
6/28/2021
3,319,559
 
 
 
Neurona Therapeutics Inc Series F
3/28/2025
2,081,218
 
 
 
Neutron Holdings Inc 4% 5/22/2027
6/4/2020
310,600
 
 
 
Neutron Holdings Inc 4% 6/12/2027
6/12/2020
82,200
 
 
 
Neutron Holdings Inc 8% 10/29/2026
10/29/2021 - 10/29/2025
2,430,728
 
 
 
NScale Global Holdings Ltd Series B
9/25/2025
2,013,364
 
 
 
Odyssey Therapeutics Inc Series B
9/30/2022
2,892,807
 
 
 
Odyssey Therapeutics Inc Series C
10/25/2023
2,212,210
 
 
 
Odyssey Therapeutics Inc Series D
6/16/2025
2,640,432
 
 
 
OpenAI Group Pbc Class A
9/3/2025
2,279,000
 
 
 
OpenAI Group Pbc Series A-3
8/4/2025
2,897,400
 
 
 
Oruka Therapeutics Inc
9/17/2025
1,534,545
 
 
 
Oura Health Oy Series D
12/18/2024
8,351,202
 
 
 
Oura Health Oy Series E
9/24/2025
30,542,936
 
 
 
Parabilis Medicines Inc Series D
11/17/2022
2,933,989
 
 
 
Parabilis Medicines Inc Series E
2/29/2024
1,261,439
 
 
 
Parabilis Medicines Inc Series F
1/6/2026
3,025,389
 
 
 
Paragon Biosciences Emalex Capital Inc Series C
2/26/2021
1,176,647
 
 
 
Paragon Biosciences Emalex Capital Inc Series D-3
5/6/2025
839,896
 
 
 
Paragon Biosciences Emalex Capital Inc Series D1
10/21/2022 - 3/13/2025
2,293,956
 
 
 
Paragon Biosciences Emalex Capital Inc Series D2
5/18/2022
134,101
 
 
 
Perceptive Capital Solutions Corp
12/5/2025
1,248,470
 
 
 
Physical Intelligence Inc Series B
10/24/2025
3,367,335
 
 
 
Prognomiq Inc
8/20/2020 - 2/16/2022
674,070
 
 
 
Quell Therapeutics Ltd Series B
11/24/2021
1,554,788
 
 
 
Rad Power Bikes Inc
1/21/2021
826,884
 
 
 
Rad Power Bikes Inc 8% 12/31/2199
10/6/2023
280,502
 
 
 
Rad Power Bikes Inc Series A
1/21/2021
107,803
 
 
 
Rad Power Bikes Inc Series C
1/21/2021
424,189
 
 
 
Rad Power Bikes Inc Series D
9/17/2021
2,104,603
 
 
 
Rad Power Bikes Inc warrants 10/6/2033
10/6/2023
0
 
 
 
Redwood Materials Series C
5/28/2021
970,302
 
 
 
Redwood Materials Series D
6/2/2023
379,977
 
 
 
Redwood Materials Series E
10/20/2025
69,932
 
 
 
Retym Inc Series C
5/17/2023 - 6/20/2023
1,574,881
 
 
 
Retym Inc Series D
1/29/2025
531,531
 
 
 
Revolut Group Holdings Ltd
12/27/2024 - 1/28/2026
5,140,708
 
 
 
Saluda Medical Inc
1/20/2022 - 10/30/2025
5,125,538
 
 
 
Scorpion Therapeutics Inc
3/5/2025
261,494
 
 
 
Scorpion Therapeutics Inc
3/5/2025
0
 
 
 
Scorpion Therapeutics Inc rights
3/5/2025
435,823
 
 
 
SiMa Technologies Inc 10% 12/31/2027
4/8/2024 - 1/5/2026
498,596
 
 
 
SiMa Technologies Inc 7.5% 12/31/2027
7/18/2025
434,800
 
 
 
SiMa Technologies Inc Series B
5/10/2021
1,535,564
 
 
 
SiMa Technologies Inc Series B1
4/25/2022 - 10/17/2022
1,190,193
 
 
 
Skyhawk Therapeutics Inc
12/19/2019 - 5/21/2021
2,925,073
 
 
 
Skyryse Inc Series B
10/21/2021
2,903,673
 
 
 
Skyryse Inc Series C
9/16/2025 - 11/21/2025
3,094,271
 
 
 
Skyryse Inc Series C-1
8/13/2024
378,171
 
 
 
Sonoma Biotherapeutics Inc Series B
7/26/2021
1,161,934
 
 
 
Sonoma Biotherapeutics Inc Series B1
7/26/2021
929,546
 
 
 
Space Exploration Technologies Corp
2/16/2021 - 12/19/2025
61,575,362
 
 
 
Space Exploration Technologies Corp Class C
4/2/2024
5,731,051
 
 
 
Space Exploration Technologies Corp Series G
9/7/2023
6,260,490
 
 
 
Space Exploration Technologies Corp Series J
9/7/2023
42,258,510
 
 
 
Space Exploration Technologies Corp Series N
8/4/2020
5,373,000
 
 
 
Stripe LLC Class B
5/18/2021
1,544,943
 
 
 
Stripe LLC Series H
3/15/2021
577,800
 
 
 
T-Knife Therapeutics Inc Series B
6/30/2021
1,392,911
 
 
 
Taalas Inc 0%
12/23/2025
2,520,461
 
 
 
Taalas Inc Series B
2/19/2025
1,647,402
 
 
 
Taalas Inc warrants
12/23/2025
508,939
 
 
 
Tenstorrent Holdings Inc 15% 12/31/2026
2/25/2026
1,579,300
 
 
 
Tenstorrent Holdings Inc Series C1
4/23/2021
1,944,778
 
 
 
Tenstorrent Holdings Inc Series D1
7/16/2024 - 1/15/2025
6,453,285
 
 
 
Tenstorrent Holdings Inc Series D2
7/17/2024
1,165,989
 
 
 
Treeline Biosciences Series A
7/30/2021 - 10/27/2022
2,221,578
 
 
 
Treeline Biosciences Series A1
10/27/2022
1,303,031
 
 
 
Triveni Bio Inc Series B
9/19/2024
2,174,907
 
 
 
Tubulis GmbH
12/11/2025
784,688
 
 
 
Valuedrive Technologies Pvt Ltd Series A
2/12/2026
222,064
 
 
 
Valuedrive Technologies Pvt Ltd Series B
2/12/2026
446,771
 
 
 
Valuedrive Technologies Pvt Ltd Series G
2/12/2026
904,357
 
 
 
Vast Data Ltd Series A
11/28/2023
1,182,533
 
 
 
Vast Data Ltd Series A1
11/28/2023
2,910,578
 
 
 
Vast Data Ltd Series A2
11/28/2023
3,348,103
 
 
 
Vast Data Ltd Series B
11/28/2023
2,664,123
 
 
 
Vast Data Ltd Series C
11/28/2023
77,660
 
 
 
Vast Data Ltd Series E
11/28/2023
5,091,504
 
 
 
Waymo LLC Series A2
5/8/2020
566,037
 
 
 
Waymo LLC Series C2
10/18/2024
1,481,367
 
 
 
Wugen Inc 0% 12/31/2199
6/14/2024
515,072
 
 
 
Wugen Inc Series B
7/9/2021
945,276
 
 
 
Wugen Inc Series C
8/22/2025 - 2/17/2026
2,516,795
 
 
 
Wugen Inc warrants 8/22/2035
8/22/2025
0
 
 
 
Xsight Labs Ltd Series D
2/16/2021
977,119
 
 
 
Xsight Labs Ltd Series F
1/11/2024 - 12/30/2024
1,661,754
 
 
 
Xsight Labs Ltd warrants 7/24/2032
1/11/2024 - 12/30/2024
0
 
 
 
Zipline International Inc Series G
6/7/2024
3,107,172
 
 
 
Zipline International Inc Series H
12/3/2025
5,001,893
 
 
 
 
Additional information on each lock-up restriction is as follows:
Security
Restriction Expiration Date
AgomAb Therapeutics NV
8/5/2026
 
 
Beta Technologies Inc
5/4/2026
 
 
Generate Biomedicines Inc
8/26/2026
 
 
Meesho
6/9/2026
 
 
Saluda Medical Inc
3/31/2027
 
 
 
Affiliated Central Funds
 
Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.
Affiliate
Value,
beginning
of period ($)
Purchases ($)
Sales
Proceeds ($)
Dividend
Income ($)
Realized
Gain (loss) ($)
Change in
Unrealized
appreciation
(depreciation) ($)
Value,
end
of period ($)
 
 
Shares,
end
of period
% ownership,
end
of period
Fidelity Cash Central Fund
6,377,073
567,950,166
568,694,291
409,221
(4,460)
-
5,628,488
5,627,363
0.0%
Fidelity Securities Lending Cash Central Fund
87,373,109
235,174,608
206,826,852
265,700
(423)
-
115,720,442
115,708,871
0.3%
Total
93,750,182
803,124,774
775,521,143
674,921
(4,883)
-
121,348,930
 
 
 
 
 
 
 
 
 
 
 
 
Amounts in the dividend income column in the above table include any capital gain distributions from underlying funds.
 
Amounts in the dividend income column for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium income received for lending certain types of securities.
Investment Valuation
Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Securities transactions are accounted for as of trade date. The Board of Trustees (the Board) has designated the Fund's investment adviser as the valuation designee responsible for the fair valuation function and performing fair value determinations as needed. The investment adviser has established a Fair Value Committee (the Committee) to carry out the day-to-day fair valuation responsibilities and has adopted policies and procedures to govern the fair valuation process and the activities of the Committee. In accordance with these fair valuation policies and procedures, which have been approved by the Board, the Fund attempts to obtain prices from one or more third party pricing services or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with the policies and procedures. Factors used in determining fair value vary by investment type and may include market or investment specific events, transaction data, estimated cash flows, and market observations of comparable investments. The frequency that the fair valuation procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee manages the Fund's fair valuation practices and maintains the fair valuation policies and procedures. The Fund's investment adviser reports to the Board information regarding the fair valuation process and related material matters.   
 
The inputs to valuation techniques used to value investments are categorized into a disclosure hierarchy consisting of three levels as shown below:
 
Level 1 - Unadjusted quoted prices in active markets for identical investments
Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)
Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)
 
Valuation techniques used to value investments by major category are as follows:
Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing service on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For any foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.
 
Securities, including private placements or other restricted securities, for which observable inputs are not available are valued using alternate valuation approaches, including the market approach, the income approach and cost approach, and are categorized as Level 3 in the hierarchy. The market approach considers factors including the price of recent investments in the same or a similar security or financial metrics of comparable securities. The income approach considers factors including expected future cash flows, security specific risks and corresponding discount rates. The cost approach considers factors including the value of the security's underlying assets and liabilities.
 
Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing services or from brokers who make markets in such securities. Convertible Corporate Bonds and Preferred Securities are valued by pricing services who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing services. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.
 
Investments in any open-end mutual funds are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.
 
Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy.
 
For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.
 
The fund's consolidated schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.
 
Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.